Phase I trial of novel kinesin spindle protein (KSP) inhibitor SB-715992 IV days 1, 8, 15 q 28 days
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: H. A. Burris, P. Lorusso, S. Jones, T. M. Guthrie, J. B. Orr, D. D. Williams, J. P. Hodge, M. Bush, J. Sabry
Institutions: Wayne State University, Sarah Cannon, Cytokinetics (United States)
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2604021223
